跳至主要内容
临床试验/NCT03987971
NCT03987971Unknown不适用

Acupuncture on GB26 to Treat Chronic Low Back Pain

Wenzhou Medical University0 个研究点目标入组 114 人开始时间: 2020年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
114
主要终点
Change in Numerical Rating Scale (NRS) score

研究概览

简要总结

This study evaluates the effecacy of acupoint GB26 based acupuncture treatment in patients with chronic low back pain. Half of the participants will partake in a 2-week acupuncture intervention, while the other half will receive a placebo treatment. The investigators hypothesize that acupuncture on GB26 reduces disability and pain more than the control intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (both male and female) with non-specific low back pain for more than three months.
  • Age range: between 20 and 60 years.
  • Willingness of the patient to participate in the study, and written informed consent signed and personally dated by the patient.
  • Chronic non-specific low back pain clinically diagnosed as repeated lumbar sourness and swelling pain or a chronic progressive process, accompanied by (i) X-ray examination to exclude lumbar vertebrate fractures, spondylolysis, spondylolisthesis and severe osteoporosis, and/or (ii) MRI with normal signal or low nucleus pulposus signal.

排除标准

  • Age less than 20 or greater than 60 years
  • Specific causes of back pain (e.g., cancer, fractures, spinal stenosis, infections)
  • Complicated back problems (e.g., prior back surgery, medico-legal issues)
  • Possible contraindications for acupuncture (e.g., coagulation disorders, cardiac pacemakers, pregnancy, seizure disorder), and conditions that might confound treatment effects or interpretation of results (e.g., severe fibromyalgia, rheumatoid arthritis)
  • Conditions making treatment difficult (e.g., paralysis, psychoses, or other severe psychiatric problems based on the judgment of a physician investigator and/or a T score >60 on the psychological assessments performed during Session 1)
  • Prior acupuncture treatment for back pain; 1 year minimum for any other condition.
  • The intent to undergo surgery during the time of involvement in the study.
  • History of cardiac, respiratory, or nervous system disease that, in the judgment of a physician investigator, precludes participation in the study because of a heightened potential for adverse outcome (e.g., asthma, claustrophobia)
  • Presence of any contraindications to MRI scanning (e.g., cardiac pacemaker, metal implants, fear of closed spaces, pregnancy)
  • Active substance abuse disorders within the last 24 months, based on subject self-report
  • Radicular knee pain extending below the knee

研究组 & 干预措施

Deep acupuncture on GB26

Experimental

干预措施: acupuncture (Other)

Superficial acupuncture on GB26

Sham Comparator

干预措施: acupuncture (Other)

waiting list

No Intervention

结局指标

主要结局

Change in Numerical Rating Scale (NRS) score

时间窗: Change from baseline NRS score at 1 weeks, 2 weeks, 4 weeks and 12 weeks

The NRS will ask patients to rate their pain intensity on an 11-point scale where 0 indicates no pain and 10 indicates worst imaginable pain

Change in Oswestry Low Back Pain Disability Questionnaire (OLDPDQ) score

时间窗: Change from baseline NRS score at 1 weeks, 2 weeks, 4 weeks and 12 weeks

The OLDPDQ score is considered the 'gold standard' of low back functional outcome tools. The questionnaire is composed of ten sections (addressing pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and travelling); for each section the possible score is 5 and, thus, the total possible score is 50. The final score is calculated as \[(sum of individual scores) / 50\] \*100 (%), and is interpreted as minimal disability (0% to 20%), moderate disability (21% to 40%), severe disability (41% to 60%), crippled (61% to 80%) or patients are either bed-bound or exaggerating their symptoms (81% to 100%).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tang Lewei

Principal Investigator

Wenzhou Medical University

相似试验